FDA Inspection 1100101 - Novartis Pharmaceuticals Corporation - August 21, 2019
FDA Inspection 1100101 for Novartis Pharmaceuticals Corporation on August 21, 2019. Classification: Voluntary Action Indicated (VAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1100101 for Novartis Pharmaceuticals Corporation on August 21, 2019. Classification: Voluntary Action Indicated (VAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
August 21, 2019
Product Type
Biologics
ID: e4fab4a0-2d49-44f2-a6c8-f6170fd44cd2
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox